CLEC2L
C-type lectin domain family 2 member L
Also known as: CLC2L_HUMAN, FLJ32986
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0C7M8
- Gene
- CLEC2L
- Ensembl
- ENSG00000236279
- Chromosome
- 7
- Canonical length
- 214 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable carbohydrate binding activity. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
214 residues, UniProt reviewed canonical sequence.
>P0C7M8|CLEC2L
1 MEPAREPPSR ARPPPPLAAR PAPAPAAPRP RSPAEAEARG PEGLLRRSGS GYEGSTSWKA
61 ALEDTTTRLL LGAIAVLLFA ILVVMSILAS KGCIKCEAPC PEDWLLYGRK CYFFSEEPRD
121 WNTGRQYCHT HEAVLAVIQS QKELEFMFKF TRREPWIGLR RVGDEFHWVN GDPFDPDTFT
181 IAGPGECVFV EPTRLVSTEC LMTRPWVCSK MAYTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLEC2L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 38 nTPM
- cerebellum: 20 nTPM
- hippocampal formation: 20 nTPM
- midbrain: 18 nTPM
- amygdala: 14 nTPM
- parathyroid gland: 13 nTPM
Single-cell type
- retinal ganglion cells: 147 nCPM
- platelets: 65 nCPM
- other brain neurons: 55 nCPM
- brain inhibitory neurons: 55 nCPM
- brain excitatory neurons: 47 nCPM
- retinal amacrine cells: 35 nCPM
Immune cell
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- pons: 73 nTPM
- cerebral cortex: 71 nTPM
- thalamus: 63 nTPM
- cerebellum: 56 nTPM
- medulla oblongata: 53 nTPM
- white matter: 35 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.53
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLEC2L as an antibody target. Whether an autoantibody or antibody against CLEC2L could matter depends on whether native CLEC2L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLEC2L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CLEC2L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...